Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
On-course Women's Pavilion also at tournament as part of the PGA TOUR's Women's Initiative, sponsored by Astellas MEMPHIS, Tenn. and NORTHBROOK, Ill., June 4, 2013 /PRNewswire/ -- The PGA TOUR and...
NORTHBROOK, Ill., May 28, 2013 – Astellas Pharma US, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that Margaret Long has been promoted to Vice President...
Read more about Astellas US Promotes Two Leaders in Government Affairs
On-course Women's Pavilion also at tournament as part of the PGA TOUR's Women's Initiative, sponsored by Astellas FORT WORTH, Texas and NORTHBROOK, Ill., May 21, 2013 /PRNewswire/ -- The PGA TOUR...
Tarceva is the First Personalized Medicine Approved for the Initial Treatment of People with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer in the United States SOUTH SAN FRANCISCO,...
SAN DIEGO, May 7, 2013 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that results of three studies of...
Follow U.S. news
